✦ LIBER ✦

Axitinib treatment in patients with cytokine-refractory metastatic renal cell cancer

✍ Scribed by Ronald M. Bukowski

Book ID: 107546659
Publisher: Current Science Inc.
Year: 2009
Tongue: English
Weight: 200 KB
Volume: 11
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-009-0013-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with metastatic re

Treatment of patients with metastatic renal cell cancer : A RAND Appropriateness Panel

✍ Ronald J. Halbert; Robert A. Figlin; Michael B. Atkins; Myriam Bernal; Thomas E. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 1 views

An early phase II trial of S-1 in Japane

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

✍ Seiji Naito; Taiji Tsukamoto; Michiyuki Usami; Hiroyuki Fujimoto; Hideyuki Akaza 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 292 KB

Phase I trial of personalized peptide va

Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients

✍ Shigetaka Suekane; Masaaki Nishitani; Masanori Noguchi; Yoshihiro Komohara; Taka 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Treatment selection for patients with me

Treatment selection for patients with metastatic renal cell carcinoma

✍ Michael B. Atkins; Toni K. Choueiri; Daniel Cho; Meredith Regan; Sabina Signoret 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Sorafenib in patients with metastatic re

Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab

✍ Jorge A. Garcia; Thomas E. Hutson; Paul Elson; C. Lance Cowey; Timothy Gilligan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

Treatment of patients with cisplatin-ref

Treatment of patients with cisplatin-refractory testicular germ-cell cancer

✍ Carsten Bokemeyer; Christian Kollmannsberger; Andreas Harstrick; Jörg Beyer; Art 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 2 views

With the use of cisplatin-based combination chemotherapy, metastatic testicular germ-cell tumors can be cured in 70% to 80% of patients. The combination of cisplatin, etoposide and bleomycine (PEB) is considered standard therapy.